Svenningsson, P., Johansson, A., Nyholm, D., Tsitsi, P., Hansson, F., Sonesson, C., & Tedroff, J. (2018). Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial. NPJ Parkinsons Dis.

Svenningsson, Per, Anders Johansson, Dag Nyholm, Panagiota Tsitsi, Fredrik Hansson, Clas Sonesson, and Joakim Tedroff. "Safety and Tolerability of IRL790 in Parkinson’s Disease With Levodopa-induced Dyskinesia—a Phase 1b Trial." NPJ Parkinsons Dis 2018.

Svenningsson, Per, et al. "Safety and Tolerability of IRL790 in Parkinson’s Disease With Levodopa-induced Dyskinesia—a Phase 1b Trial." NPJ Parkinsons Dis 2018.